CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $93,955,000 | -18.8% | 4,016,873 | 0.0% | 10.19% | -40.1% |
| Q4 2020 | $115,686,000 | +42.2% | 4,016,873 | 0.0% | 17.01% | +6.8% |
| Q3 2020 | $81,382,000 | -32.6% | 4,016,873 | 0.0% | 15.92% | -44.9% |
| Q2 2020 | $120,707,000 | -4.4% | 4,016,873 | 0.0% | 28.90% | -15.5% |
| Q1 2020 | $126,250,000 | – | 4,016,873 | – | 34.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |